Drug therapies treatment

Design individualized drug therapy treatment plans for patients with (1) sinus bradycardia (2) AV nodal blockade (3) AF (4) PSVT (5) VPDs (6) VT (including torsades de pointes) and (7) VF. 

Elia J, Ambrosini PJ, Rapoport JL. Drug therapy treatment of attention-deficit-hyperactivity disorder. New Engl J Med 1999 340(10) 780-788. 

Drazen, J.M., Israel, E., O Byrne, P.M. (1999) Drug therapy treatment of asthma with drugs modifying the leukotriene pathway. New Engl. J. Med. 340, 197-206. 

Purerfellner H. Recent developments in cardiovascular drug therapy treatment of atrial arrhythmias with new class III drags and beyond. Curr Med Chem Cardiovasc Hematol Agents. 2004 2 79-91. 

Patient satisfaction and quality of life are the two most common methods of measuring the humanistic outcomes of care. Improvements in patients quality of life have not been consistently demonstrated however, there is evidence that many of these studies purporting to provide pharmaceutical care were in fact disease state management or specific drug-focused programs in which pharmacists did not assume responsibility for all of the patients drug therapy treatment goals. 

While advances in the symptomatic drug therapy (summarized below) have certainly improved the lives of many Parkinson patients, the goal of current research is to develop treatments that can prevent, retard or reverse the death of dopaminergic neurons in the substantia nigra pats compacta (and of other neurons involved in the pathogenesis of Parkinson s disease not mentioned in this essay). 

The expected outcomes for the patient may include an optimal response to drug therapy and an understanding of and compliance with the prescribed treatment regimen. 

Promoting an Optimal Response to Therapy Treatment with a leprostatic drug may require many years. These patients are faced with long-term medical and drug therapy and possibly severe disfigurement. The nurse must spend time with these patients, allowing them to verbalize their anxieties, problems, and fears. 

The expected outcomes for the patient depend on the reason for administration of the NSAID but may include an optimal response to drug therapy, which includes relief of pain and fever, management of adverse reactions, and an understanding of and compliance with the prescribed treatment regimen. 

Promoting an Optimal Response to Therapy The patient with a musculoskeletal disorder may be in acute pain or have longstanding mild to moderate pain, which can be just as difficult to tolerate as severe pain. Along with pain, there may be skeletal deformities, such as the joint deformities seen with advanced rheumatoid arthritis. For many musculoskeletal conditions, drug therapy is a major treatment modality. Therapy with these drugs may keep the disorder under control (eg, therapy for gout), improve the patient s ability to carry out the activities of daily living, or make the pain and discomfort tolerable. 

SKELETAL MUSCLE RELAXANTS. The nurse gives these drug with food to minimize gastrointestinal distress, hi addition to drug therapy, rest, physical therapy, and other measures may be part of treatment. 

The following isa suggested dosing schedule for the administration of midodrine shortly before arising in the morning, midday, and late afternoon (not after 6 00 fm). The nurse should continue drug therapy only in the patient whose orthostatic hypotension improves during the initial treatment. 

Inform the primary health care provider if asthma symptoms do not improve within 4 weeks of initiating treatment. The primary health care provider may discontinue the drug therapy. 

To ensure lifetime compliance with the prescribed therapeutic regimen, the nurse emphasizes the importance of drug therapy, as well as other treatments recommended by the primary care provider. The nurse describes the adverse reactions that may be seen with a particular antihypertensive drug and advises the patient to contact the primary care provider if any should occur. 

Mr. Elliott, age 42 years, had a UTI8 weeks ago. He failed to see his primary health care provider for a follow-up urine sample 2 weeks after completing his course of drug therapy. Mr. Elliot is in to see his primary health care provider because his symptoms of a UTI have recurred. The primary health care provider suspects that Mr. Elliott may not have followed instructions regarding treatment for his UTI. Analyze the situation to determine what points you would stress in a teaching plan for this patient. 

Factorial trial designs are used to evaluate, simultaneously, two or more treatments through the use of varying combinations of the treatments. An example of a simple trial to evaluate drugs A and B is illustrated in Table 5.1. These trials are particularly relevant where multiple drug therapies are anticipated. 

---